Nematodicidal activity of flubendazole and its reduced metabolite on a murine model of trichinella spiralis infection

Chemotherapy

Volumn 58, Issue 4, 2012, Pages 295-298

  Urbizu, Lucía ^a   Confalonieri, Alejandra ^a   Sánchez Bruni, Sergio ^a   Lanusse, Carlos ^a   Alvarez, Luis Ignacio ^a  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Efficacy; Flubendazole; Reduced flubendazole; Trichinella spiralis

Indexed keywords

CARBOXYMETHYLCELLULOSE; CYCLODEXTRIN; DRUG METABOLITE; FLUBENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MOUSE; NEMATODICIDAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; TRICHINELLA SPIRALIS; TRICHINOSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; CARBOXYMETHYLCELLULOSE SODIUM; CYCLODEXTRINS; DISEASE MODELS, ANIMAL; MEBENDAZOLE; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION; TRICHINELLA SPIRALIS; TRICHINELLOSIS;

EID: 84867448612     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000342924     Document Type: Article

References (24)

1. Ceballos L, Elissondo M, Sánchez Bruni S, Denegri G, Alvarez L, Lanusse C: Flubendazole in cystic echinococcosis therapy: pharmaco- parasitological evaluation in mice. Parasitol Int 2009; 58: 354-358.
2. Goudah A, Hasabelnaby B: Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations. Chemotherapy 2010; 56: 26-31.
3. Tripathi R, Khanna K, Dwivedi A: Efficacy of novel oral formulations of-/-artemether against multidrug-resistant malaria in mice. Chemotherapy 2010; 56: 178-183.
4. McKellar Q, Scott E: The benzimidazole antihelmintic agents-a review. J Vet Pharmacol Ther 1990; 13: 223-247.
5. Lanusse CE, Prichard RK: Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metab Rev 1993; 25: 235-279.
6. Ceballos L, Alvarez LI, Sanchez Bruni SF, Elissondo C, Dopchiz M, Denegri G, Torrado JJ, Lanusse CE: Development of a cyclodextrin-based flubendazole formulation to control secondary echinococcosis: pharmacokinetics, hydatid cyst morphology and efficacy in mice. J Vet Pharmacol Ther 2006; 29: 85-86.
7. Ceballos L, Elissondo C, Sánchez Bruni S, Denegri G, Lanusse C, Alvarez L: Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice. Antimicrob Agents Chemother 2011; 55: 5861-5867.
8. Ceballos L, Elissondo M, Sánchez Bruni S, Confalonieri A, Denegri G, Alvarez L, Lanusse C: Chemoprophylactic activity of flubendazole in cystc echinococcosis. Chemotherapy 2010; 56: 386-392.
9. Gottschall D, Theodorides V, Wang R: The metabolism of benzimidazole anthelmintics. Parasitol Today 1990; 6: 118-124.
10. Fetterer RH, Rew RS: Interaction of Fasciola hepatica with albendazole and its metabolites. J Vet Pharmacol Ther 1984; 7: 113-118.
11. Alvarez LI, Sánchez SF, Lanusse CE: In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep. J Vet Pharmacol Ther 1999; 22: 77-86.
12. Alvarez LI, Imperiale FA, Sánchez SF, Murno GA, Lanusse CE: Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Vet Parasitol 2000; 94: 75-89.
13. Lacey E: Mode of action of benzimidazoles. Parasitol Today 1990; 6: 112-115.
14. Lubega GW, Prichard RK: Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. Exp Parasitol 1991; 73: 203-213.
15. Petersen MB, Friis C, Bjørn H: A new in vitro assay of benzimidazole activity against adult Oesophagostomum dentatum . Int J Parasitol 1997; 27: 1333-1339.
16. De Ruyck H, Daeseleire E, Grijspeerdt K, De Ridder H, Van Renterghem R, Huyghebaert G: Determination of flubendazole and its metabolites in eggs and poultry muscle with liquid chromatography-tandem mass spectrometry. J Agric Food Chem 2001; 49: 610-617.
17. Moreno L, Alvarez L, Mottier L, Virkel G, Sanchez Bruni S, Lanusse C: Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability. J Vet Pharmacol Ther 2004; 27: 299-308.
18. Alvarez L, Moreno G, Moreno L, Ceballos L, Shaw L, Fairweather I, Lanusse C: Comparative assessment of albendazole and riclabendazole ovicidal activity on Fasciola hepatica eggs. Vet Parasitol 2009; 164: 211-216.
19. Ruiz ML, Castaño Zubieta R, Martinez ML, Schapiro J, Cutullé C, Morici G, Balbiani G, Castro M, Caracostantogolo J: Guía de procedimientos para el diagnóstico de trichinellosis en Medicina Veterinaria. Área de Parasitología del Instituto de Patobiología, INTA, Argentina, 1999.
20. Lopez-García ML, Torrado S, Torrado JJ, Martínez AR, Bolás F: Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice. Int J Parasitol 1997; 27: 781-785.
21. Denham D, Martinez AR: Studies with methyiidine and Trichinella spiralis . 2. The use of the drugs to study the rate of larval production in mice. J Helminthol 1970; 44: 357-363.
22. Mottier L, Alvarez L, Ceballos L, Lanusse C: Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Exp Parasitol 2006; 113: 49-57.
23. García JJ, Torrado JJ, Bolas F: Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes. Parasite 2001; 8: 188-190.
24. García JJ, Bolás F, Torrado JJ: Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. Int J Pharm 2003; 250: 351-358.